Tablet, Extended Release
Guaifenesin And Pseudoephedrine Hcl
Guaifenesin + Pseudoephedrine Hydrochloride
2 ACTIVE SUPPLIERS - US
openFDA · updated weekly
US3 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost - not a retail quote.
$0.423
Latest avg · Sep 23, 2026
+1%
Since Feb 18, 2026
2
Active US suppliers